CFM
TERN icon

Cornerstone Financial Management’s Terns Pharmaceuticals TERN Stock Holding History

Cornerstone Financial Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58
Closed -$3.06K – 1549
2026
Q1 		$3.06K Hold
58
– – ﹤0.01% 618
2025
Q4 		$2.34K Buy
+58
New +$1.34K ﹤0.01% 638

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cornerstone Financial Management's TERN Position: Q2 2026 in Review

Cornerstone Financial Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 58 shares — an estimated $3.06K sold.

Cornerstone Financial Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $3.06K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Cornerstone Financial Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Cornerstone Financial Management sold 58 Terns Pharmaceuticals shares in Q2 2026, an estimated $3.06K.
  • Cornerstone Financial Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Cornerstone Financial Management's Terns Pharmaceuticals position peaked at $3.06K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.